Success Metrics

Clinical Success Rate
93.3%

Based on 210 completed trials

Completion Rate
93%(210/225)
Active Trials
20(7%)
Results Posted
37%(77 trials)
Terminated
15(5%)

Phase Distribution

Ph early_phase_1
2
1%
Ph phase_2
35
12%
Ph not_applicable
30
10%
Ph phase_1
81
27%
Ph phase_3
54
18%
Ph phase_4
54
18%

Phase Distribution

83

Early Stage

35

Mid Stage

108

Late Stage

Phase Distribution256 total trials
Early Phase 1First-in-human
2(0.8%)
Phase 1Safety & dosage
81(31.6%)
Phase 2Efficacy & side effects
35(13.7%)
Phase 3Large-scale testing
54(21.1%)
Phase 4Post-market surveillance
54(21.1%)
N/ANon-phased studies
30(11.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

89.7%

210 of 234 finished

Non-Completion Rate

10.3%

24 ended early

Currently Active

20

trials recruiting

Total Trials

299

all time

Status Distribution
Active(24)
Completed(210)
Terminated(24)
Other(41)

Detailed Status

Completed210
unknown41
Terminated15
Recruiting15
Withdrawn9
Active, not recruiting5

Development Timeline

Analytics

Development Status

Total Trials
299
Active
20
Success Rate
93.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (0.8%)
Phase 181 (31.6%)
Phase 235 (13.7%)
Phase 354 (21.1%)
Phase 454 (21.1%)
N/A30 (11.7%)

Trials by Status

withdrawn93%
not_yet_recruiting31%
enrolling_by_invitation10%
completed21070%
terminated155%
recruiting155%
unknown4114%
active_not_recruiting52%

Recent Activity

Clinical Trials (299)

Showing 20 of 299 trialsScroll for more
NCT04736420

Replication of the EINSTEIN-DVT Anticoagulant Trial in Healthcare Claims Data

Active Not Recruiting
NCT03684564Phase 2

RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome

Completed
NCT06289504Phase 1

A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blood of Participants With Excess Body Weight

Completed
NCT03702582Phase 3

Rivaroxaban vs. Warfarin for Post Cardiac Surgery Atrial Fibrillation

Completed
NCT03862859Phase 4

The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis

Recruiting
NCT06278051

An Observational Study to Learn More About How Safe Treatment With Rivaroxaban is in Children in Japan With Venous Thromboembolism

Completed
NCT03061006Phase 4

Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients With Non-Valvular Atrial Fibrillation

Completed
NCT06686628Phase 1

An Open-label, DDI Study to Investigate the Effects of Amlitelimab on the PK of Selected Cytochrome P450 Substrates

Completed
NCT00162474Not Applicable

Determinants of Warfarin Metabolism

Recruiting
NCT02783040Phase 1

Interaction of BI 425809 With Midazolam, Warfarin, Omeprazole and Digoxin

Completed
NCT07523347Not Applicable

Efficacy and Safety of Oral Rivaroxaban in Cerebrosinovenous Thrombosis

Completed
NCT02810704Phase 4

Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement

Completed
NCT07502001Phase 1

Influence of HDM1005 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin

Not Yet Recruiting
NCT07456085Phase 3

Rivaroxaban vs Warfarin in Patients With Mechanical Heart Valves

Enrolling By Invitation
NCT07471139Phase 3

SWITCH: Apixaban vs Vitamin K in HM3

Not Yet Recruiting
NCT06655376Phase 4

Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients With Assist Device

Recruiting
NCT07434661Phase 3

Apixaban VS Warfarin in AF Pts First Three Months After Repair or BIO AVR MVR

Not Yet Recruiting
NCT01391962Phase 2

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

Completed
NCT07358416

Complications and Antiplatelet and Anticoagulant Therapy in Vascular Surgery.

Active Not Recruiting
NCT07331389Phase 1

A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin

Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
299